Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor

Journal of Immunology

Volumn 182, Issue 1, 2009, Pages 477-488

  Frascaroli, Giada ^a   Varani, Stefania ^b   Blankenhorn, Nina ^a   Pretsch, Robert ^a   Bacher, Michael ^c   Leng, Lin ^d   Bucala, Richard ^d   Landini, Maria Paola ^b   Mertens, Thomas ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; GROWTH FACTOR; MACROPHAGE MIGRATION INHIBITION FACTOR; CHEMOKINE RECEPTOR; ISOMERASE; MIF PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ARTICLE; CELL ACTIVITY; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; CYTOSKELETON; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; INFECTION SENSITIVITY; INFLAMMATION; MACROPHAGE MIGRATION; MICROTUBULE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; VIRUS STRAIN; CELL CULTURE; CYTOMEGALOVIRUS; DRUG ANTAGONISM; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MACROPHAGE; METABOLISM; MIGRATION INHIBITION; MONOCYTE; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY; SECRETION; VIROLOGY; VIRUS REPLICATION;

CELL MIGRATION INHIBITION; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOSKELETON; DOWN-REGULATION; HUMANS; IMMUNE TOLERANCE; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MONOCYTES; RECEPTORS, CHEMOKINE; VIRUS REPLICATION;

EID: 59849119429     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.1.477     Document Type: Article

References (61)

1. Stoy, N. 2001. Macrophage biology and pathobiology in the evolution of immune responses: a functional analysis. Pathobiology 69: 179-211.
2. Ross, J. A. K., M. J. Auger, T. A. Hamilton, P. Paglia, M. P. Colombo, W. Zink, L. Ryan, H. E. Gendelman, J.-P. Heale, D. P. Speert, et al. 2002. The Macrophage. Oxford University Press, New York, NY.
3. Mocarski, E. S., Jr. 2002. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol. 10: 332-339.
4. Taylor-Wiedeman, J., J. G. Sissons, L. K. Borysiewicz, and J. H. Sinclair. 1991. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72: 2059-2064.
5. Sinzger, C., B. Plachter, A. Grefte, T. H. The, and G. Jahn. 1996. Tissue macrophages are infected by human cytomegalovirus in vivo. J. Infect. Dis. 173: 240-245.
6. Soderberg-Naucler, C. 2006. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J. Intern. Med. 259: 219-246.
7. Liu, R., M. Moroi, M. Yamamoto, T. Kubota, T. Ono, A. Funatsu, H. Komatsu, T. Tsuji, H. Hara, H. Hara, et al. 2006. Presence and severity of Chlamydia pneumoniae and cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes. Int. Heart J. 47: 511-519.
8. Rahbar, A., L. Bostrom, U. Lagerstedt, I. Magnusson, C. Soderberg-Naucler, and V. A. Sundqvist. 2003. Evidence of active cytomegalovirus infection and increased production of IL-6 in tissue specimens obtained from patients with inflammatory bowel diseases. Inflamm. Bowel. Dis. 9: 154-161.
9. Mehraein, Y., C. Lennerz, S. Ehlhardt, K. Remberger, A. Ojak, and K. D. Zang. 2004. Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNAand DNA-in situ hybridization. Mod. Pathol. 17: 781-789.
10. Díaz, F., J. C. Urkijo, F. Mendoza, J. M. de la Viuda, M. Blanco, M. Flores, and P. Berdonces. 2006. Systemic lupus erythematosus associated with acute cytomegalovirus infection. J. Clin. Rheumatol. 12: 263-264.
11. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25: 677-686.
12. Ridley, A. J., M. A. Schwartz, K. Burridge, R. A. Firtel, M. H. Ginsberg, G. Borisy, J. T. Parsons, and A. R. Horwitz. 2003. Cell migration: integrating signals from front to back. Science 302: 1704-1709.
13. Zicha, D., W. E. Allen, P. M. Brickell, C. Kinnon, G. A. Dunn, G. E. Jones, and A. J. Thrasher. 1998. Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br. J. Haematol. 101: 659-665.
14. Moutaftsi, M., P. Brennan, S. A. Spector, and Z. Tabi. 2004. Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells. J. Virol. 78: 3046-3054.
15. Varani, S., G. Frascaroli, M. Homman-Loudiyi, S. Feld, M. P. Landini, and C. Söderberg-Nauclér. 2005. Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5. J. Leukocyte Biol. 77: 219-228.
16. Frascaroli, G., S. Varani, B. Moepps, C. Sinzger, M. P. Landini, and T. Mertens. 2006. Human cytomegalovirus subverts the functions of monocytes, impairing chemokine-mediated migration and leukocyte recruitment. J. Virol. 80: 7578-7589.
17. Young, D. A., L. D. Lowe, and S. C. Clark. 1990. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture: analysis of macrophage antibody-dependent cellular cytotoxicity. J. Immunol. 145: 607-615.
18. Goodwin, C. J., S. J. Holt, S. Downes, and N. J. Marshall. 1995. Microculture tetrazolium assays: a comparison between two new tetrazolium salts, XTT and MTS. J. Immunol. Methods 179: 95-103.
19. Goodrum, F., C. T. Jordan, S. S. Terhune, K. High, and T. Shenk. 2004. Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations. Blood 104: 687-695.
20. Wentworth, B. B., and L. French. 1970. Plaque assay of cytomegalovirus strains of human origin. Proc. Soc. Exp. Biol. Med. 135: 253-258.
21. Bacher, M., M. Eickmann, J. Schrader, D. Gemsa, and A. Heiske. 2002. Human cytomegalovirus-mediated induction of MIF in fibroblasts. Virology 299: 32-37.
22. Sozzani, S., S. Ghezzi, G. Iannolo, W. Luini, A. Borsatti, N. Polentarutti, A. Sica, M. Locati, C. Mackay, T. N. Wells, et al. 1998. Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J. Exp. Med. 187: 439-444.
23. Wang, J. M., G. J. Cianciolo, R. Snyderman, and A. Mantovani. 1986. Coexistence of a chemotactic factor and a retroviral P15E-related chemotaxis inhibitor in human tumor cell culture supernatants. J. Immunol. 137: 2726-2732.
24. Warren, J. C., A. Rutkowski, and L. Cassimeris. 2006. Infection with replicationdeficient adenovirus induces changes in the dynamic instability of host cell microtubules. Mol. Biol. Cell. 17: 3557-3568.
25. Naito, M., S. Umeda, K. Takahashi, and L. D. Shultz. 1997. Macrophage differentiation and granulomatous inflammation in osteopetrotic mice (op/op) defective in the production of CSF-1. Mol. Reprod. Dev. 46: 85-91.
26. Akagawa, K. S. 2002. Functional heterogeneity of colony-stimulating factorinduced human monocyte-derived macrophages. Int. J. Hematol. 76: 27-34.
27. Riegler, S., H. Hebart, H. Einsele, P. Brossart, G. Jahn, and C. Sinzger. 2000. Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J. Gen. Virol. 81: 393-399.
28. Sinzger, C., K. Eberhardt, Y. Cavignac, C. Weinstock, T. Kessler, G. Jahn, and J. L. Davignon. 2006. Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules. J Gen. Virol. 87: 1853-1862.
29. Barleon, B., S. Sozzani, D. Zhou, H. A. Weich, A. Mantovani, and D. Marme. 1996. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87: 3336-3343.
30. Linder, S., and M. Aepfelbacher. 2003. Podosomes: adhesion hot-spots of invasive cells. Trends Cell Biol. 13: 376-385.
31. Jun, C. D., M. K. Han, U. H. Kim, and H. T. Chung. 1996. Nitric oxide induces ADP-ribosylation of actin in murine macrophages: association with the inhibition of pseudopodia formation, phagocytic activity, and adherence on a laminin substratum. Cell Immunol. 174: 25-34.
32. Bernhagen, J., R. A. Mitchell, T. Calandra, W. Voelter, A. Cerami, and R. Bucala. 1994. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33: 14144-14155.
33. David, J. R. 1966. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. USA 56: 72-77.
34. Lind, M., M. C. Trindade, Y. Nakashima, D. J. Schurman, S. B. Goodman, and L. Smith. 1999. Chemotaxis and activation of particle-challenged human monocytes in response to monocyte migration inhibitory factor and C-C chemokines. J. Biomed. Mater. Res. 48: 246-250.
35. White, E. S., S. R. Strom, N. L. Wys, and D. A. Arenberg. 2001. Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity. J. Immunol. 166: 7549-7555.
36. Hermanowski-Vosatka, A., S. S. Mundt, J. M. Ayala, S. Goyal, W. A. Hanlon, R. M. Czerwinski, S. D. Wright, and C. P. Whitman. 1999. Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration. Biochemistry 38: 12841-12849.
37. Ridley, A. J. 2001. Rho proteins, PI 3-kinases, and monocyte/macrophage motility. FEBS Lett. 498: 168-171.
38. Bernhagen, J., R. Krohn, H. Lue, J. L. Gregory, A. Zernecke, R. R. Koenen, M. Dewor, I. Georgiev, A. Schober, L. Leng, et al. 2007. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13: 587-596.
39. Salentin, R., D. Gemsa, H. Sprenger, and A. Kaufmann. 2003. Chemokine receptor expression and chemotactic responsiveness of human monocytes after in-fluenza A virus infection. J. Leukocyte Biol. 74: 252-259.
40. Kleinerman, E. S., C. A. Daniels, R. P. Polisson, and R. Snyderman. 1976. Effect of virus infection on the inflammatory response: depression of macrophage accumulation in influenza-infected mice. Am. J. Pathol. 85: 373-382.
41. Zhao, C., M. W. Wood, E. E. Galyov, U. E. Hopken, M. Lipp, H. C. Bodmer, D. F. Tough, and R. W. Carter. 2006. Salmonella typhimurium infection triggers dendritic cells and macrophages to adopt distinct migration patterns in vivo. Eur. J. Immunol. 36: 2939-2950.
42. Da Gama, L. M., F. L. Ribeiro-Gomes, U. Guimaraes, Jr., and A. C. Arnholdt. 2004. Reduction in adhesiveness to extracellular matrix components, modulation of adhesion molecules and in vivo migration of murine macrophages infected with Toxoplasma gondii. Microbes Infect. 6: 1287-1296.
43. Ibarrondo, F. J., R. Choi, Y. Z. Geng, J. Canon, O. Rey, G. C. Baldwin, and P. Krogstad. 2001. HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. AIDS Res. Hum. Retroviruses 17: 1489-1500.
44. Stegelmann, F., M. Bastian, K. Swoboda, R. Bhat, V. Kiessler, A. M. Krensky, M. Roellinghoff, R. L. Modlin, and S. Stenger. 2005. Coordinate expression of CC chemokine ligand 5, granulysin, and perforin in CD8+ T cells provides a host defense mechanism against Mycobacterium tuberculosis. J. Immunol. 175: 7474-7483.
45. Raftery, M. J., M. Schwab, S. M. Eibert, Y. Samstag, H. Walczak, and G. Schonrich. 2001. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 15: 997-1009.
46. Grigoleit, U., S. Riegler, H. Einsele, S. K. Laib, G. Jahn, H. Hebart, P. Brossart, F. Frank, and C. Sinzger. 2002. Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cells. Br. J. Haematol. 119: 189-198.
47. Soderberg-Naucler, C., K. N. Fish, and J. A. Nelson. 1997. Interferon-γ and tumor necrosis factor-α specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J. Clin. Invest. 100: 3154-3163.
48. Hummel, M., Z. Zhang, S. Yan, I. DePlaen, P. Golia, T. Varghese, G. Thomas, and M. I. Abecassis. 2001. Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency. J. Virol. 75: 4814-4822.
49. Van, F. R., and Z. A. Cohn. 1968. The origin and kinetics of mononuclear phagocytes. J. Exp. Med. 128: 415-435.
50. + monocytes is differentiation dependent. J. Virol. 75: 7543-7554.
51. Bellingan, G. J., H. Caldwell, S. E. Howie, I. Dransfield, and C. Haslett. 1996. In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J. Immunol. 157: 2577-2585.
52. Fish, K. N., W. Britt, and J. A. Nelson. 1996. A novel mechanism for persistence of human cytomegalovirus in macrophages. J. Virol. 70: 1855-1862.
53. Calandra, T., J. Bernhagen, C. N. Metz, L. A. Spiegel, M. Bacher, T. Donnelly, A. Cerami, and R. Bucala. 1995. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377: 68-71.
54. Arndt, U., G. Wennemuth, P. Barth, M. Nain, Y. Al-Abed, A. Meinhardt, D. Gemsa, and M. Bacher. 2002. Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection. J. Virol. 76: 9298-9306.
55. Lubetsky, J. B., A. Dios, J. Han, B. Aljabari, B. Ruzsicska, R. Mitchell, E. Lolis, and Y. Al-Abed. 2002. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents. J. Biol. Chem. 277: 24976-24982.
56. Flieger, O., A. Engling, R. Bucala, H. Lue, W. Nickel, and J. Bernhagen. 2003. Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter. FEBS Lett. 551: 78-86.
57. Rupreht, R. R., B. Moyetic, A. Franckz, M. Matis, M. Skoberne, V. Galvani, T. Malovrh, V. Kotnik, and S. Curin, V. 2000. Murine monoclonal antibodies directed against human recombinant macrophage migration inhibitory factor. Pflugers Arch. 440: R78-R80.
58. Wang, X., D. Y. Huang, S. M. Huong, and E. S. Huang. 2005. Integrin αvβ3 is a coreceptor for human cytomegalovirus. Nat. Med. 11: 515-521.
59. Swant, J. D., B. E. Rendon, M. Symons, and R. A. Mitchell. 2005. Rho GTPasedependent signaling is required for macrophage migration inhibitory factor-mediated expression of cyclin D1. J. Biol. Chem. 280: 23066-23072.
60. Rendon, B. E., T. Roger, I. Teneng, M. Zhao, Y. Al-Abed, T. Calandra, and R. A. Mitchell. 2007. Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J. Biol. Chem. 282: 29910-29918.
61. Kim, J. S., J. G. Kim, M. Y. Moon, C. Y. Jeon, H. Y. Won, H. J. Kim, Y. J. Jeon, J. Y. Seo, J. I. Kim, J. Kim, et al. 2006. Transforming growth factor-β1 regulates macrophage migration via RhoA. Blood 108: 1821-1829.